Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
06/2007
06/07/2007WO2007062494A1 Orally absorbed pharmaceutical formulation and method of administration
06/07/2007WO2007047047A3 Polymorph transformation of zolpidem in tablet matrix
06/07/2007WO2007046890A8 Lozenge for treatment of dry mouth and related conditions
06/07/2007WO2007045353A3 Combined preparation of o-acetylsalicylic acid salts
06/07/2007WO2007044968A3 Stable, durable granules with active agents
06/07/2007WO2007044681A3 Reduction of saltiness with sweeteners
06/07/2007WO2007043702A9 Agent for applying to mucosa and method for production thereof
06/07/2007WO2007033110A3 Liposomes for treatment of multiple myeloma
06/07/2007WO2007031753A3 Topical film-forming monophasic formulations
06/07/2007WO2007031326A3 3-(2-dimethylaminomethyl cyclohexyl) phenol retard formulation
06/07/2007WO2007027315A9 A biological bypass bridge with sodium channels, calcium channels and/or potassium channels to compensate for conduction block in the heart
06/07/2007WO2007024810A8 Compositions and methods for the treatment of wounds and the reduction of scar formation
06/07/2007WO2007021946A3 Silylamine modified nanoparticulate carriers
06/07/2007WO2007020507A8 Medicinal forms of phospholipid preparations and methods for their preparation
06/07/2007WO2007020204A3 Hfc solution formulations for inhalation containing salbutamol hydrochloride or salbutamol citrate
06/07/2007WO2007017196A3 Oil-in-water emulsions
06/07/2007WO2007010369B1 Sustained release formulation of alprazolam
06/07/2007WO2007009703A3 New formulations of substituted pyrazoline compounds
06/07/2007WO2007008666A3 Compositions and methods for improving vision using adherent thin films
06/07/2007WO2007005421A3 Long lasting alginate dry eye, related methods of manufacture and methods of use
06/07/2007WO2007002709A3 Complexation of metal ions with polypeptides
06/07/2007WO2006135846A3 Methods and systems for neural maintenance and regeneration
06/07/2007WO2006135696A3 Method for handling adhesive laminate sections
06/07/2007WO2006131570A3 Method for producing an active substance-containing composite material
06/07/2007WO2006126214A3 Injectable compositions and process for preparation of such compositions
06/07/2007WO2006123329A3 Disposable dispenser for patient infusion
06/07/2007WO2006122249A3 Use of plasmin for preventing of reducing the rate of the progression of non-proliferative diabetic retinopathy and the treatment of other ocular conditions
06/07/2007WO2006122069A3 Formulations of mast cell stabilizing agents for delivery to the colon
06/07/2007WO2006113407A3 Hydrogel bioscaffoldings and biomedical device coatings
06/07/2007WO2006103672A3 Spherically shaped substances
06/07/2007WO2006049564A8 New modified release pellet formulations for proton pump inhibitors
06/07/2007WO2006041538A3 A mixture for transdermal delivery of low and high molecular weight compounds
06/07/2007WO2006034249A3 Antimicrobial amorphous compositions
06/07/2007WO2006009679A3 Oral care compositions
06/07/2007WO2005117828A3 Phototherapy systems and methods
06/07/2007WO2005115418A3 New hydroxapatite calcium phosphates, their method of preparation and their applications
06/07/2007WO2005110418A3 Transdermal administration of phycotoxins
06/07/2007WO2005104712A3 Dpi formulation containing sulfoalkyl ether cyclodextrin
06/07/2007WO2005065660A3 Ziprasidone formulations
06/07/2007WO2005020918A3 Ultrasonic concentration of drug delivery capsules
06/07/2007WO2004112702A3 Low dose pharmaceutical powders for inhalation
06/07/2007US20070129708 Devices, systems and methods for medicament delivery
06/07/2007US20070129585 Process for the preparation of 1-octene
06/07/2007US20070129448 Compositions and methods of delivery of pharmacological agents
06/07/2007US20070129340 Ed-71 preparation
06/07/2007US20070129328 Pharmaceutical compositions of neurokinin receptor antagonists and cyclodextrin and methods for improved injection site toleration
06/07/2007US20070129318 Antisense oligonucleotide having anticancerous activity
06/07/2007US20070129312 Convalent conjugates of biologically-active compounds with amino acids and amino acid derivatives for targeting to physiologically-protected sites
06/07/2007US20070129299 Compositions and methods for enhanced mucosal delivery of pyy peptide
06/07/2007US20070129286 Treatment Solution and Method for Preventing Posterior Capsular Opacification by Selectively Inducing Detachment And/Or Death of Lens Epithelial Cells
06/07/2007US20070128703 An immobilized acceptor having at least two sugar units is contacted with Pasteurella multocida transferases selected from pmHAS, pmCS, pmHS, PglA, in a reaction medium with a sugar precursor selected from uridine diphosphate (UDP)-glucosamine, UDP-N-acetylglucosamine, or UDP-N-acetylgalactosamine
06/07/2007US20070128575 Implantable devices for chemonucleolysis of intervertebral discs
06/07/2007US20070128299 Functional beverage and composition
06/07/2007US20070128292 rich in polyunsaturated fatty acids such as linolenic acid, eicosapentaenoic acid, docosahexaenoic acid and antioxidant; cardiovascular diseases
06/07/2007US20070128291 Method and Apparatus for Forming Chromonic Nanoparticles
06/07/2007US20070128290 Novel formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
06/07/2007US20070128289 Nano-and/or micro-particulate formulations for local injection-based treatment of vascular diseases
06/07/2007US20070128288 Artificial tears or vehicles for ophthalmic drugs; viscosity; hydroxypropyl methylcellulose and a combination of two other polymers: guar gum, a carboxyvinyl polymer (polymer of acrylic acid crosslinked with allyl sucrose or allylpentaerythritol), hydroxyethyl cellulose or dextran, dry eye
06/07/2007US20070128287 Dermal composition for external use
06/07/2007US20070128286 Production of Polymer Matrix for Delivery (PMD)
06/07/2007US20070128285 Pharmaceutical composition for oral administration
06/07/2007US20070128284 Using sulfur-containing antioxidant, such as N-acetylcysteine in delivery vehicle including polyoxyethylene-polyoxypropylene block copolymers for therapy of dry mouth and/or thickened saliva resulting from altered, reduced or absent saliva flow
06/07/2007US20070128283 Oral osmotic drug delivery system
06/07/2007US20070128282 Oral osmotic drug delivery system
06/07/2007US20070128281 Oral osmotic drug delivery system
06/07/2007US20070128280 Oral osmotic drug delivery system
06/07/2007US20070128279 Extended Release Dosage Form
06/07/2007US20070128278 Pharmaceutical formulations
06/07/2007US20070128277 Coated tablets
06/07/2007US20070128276 Controlled release compositions comprising nimesulide
06/07/2007US20070128275 Trazodone composition for once a day administration
06/07/2007US20070128274 dry coating solid dosage forms using powdered materials which avoids the need for organic solvents; spraying of a mixture of finely ground particles of polymer and other materials onto the solid dosage surface without using any solvent, and then heating
06/07/2007US20070128273 Composition containing medicine extremely slightly soluble in water and method for preparation thereof
06/07/2007US20070128272 Multi-vitamin and mineral supplement
06/07/2007US20070128271 Formulation and manufacturing process for calcium acetate capsules
06/07/2007US20070128270 Pharmaceutical formulations containing 5-cyclopropyl-2-(4-fluorophenyl)-6-[(2-hydroxyethyl)(methylsulfonyl)amino]-n-methyl-1-benzofuran-3-carboxamide and method of making the same
06/07/2007US20070128269 Sustained drug release compositions
06/07/2007US20070128268 Pharmaceutical compositions comprising an antibiotic
06/07/2007US20070128267 Blends of gelling and non-gelling starches with gellan gums and plasticizer
06/07/2007US20070128266 Pharmaceutical or dietary compositions based on short-chain fatty acids and complex sugars, for intestinal disorders
06/07/2007US20070128265 Regulation of cell proliferation and differentiation using topically applied peptides
06/07/2007US20070128264 Method of cancer screening and method of cancer treatment
06/07/2007US20070128263 Transdermal therapeutic system
06/07/2007US20070128262 Package containing adhesive patch and method of inhibiting drug migration
06/07/2007US20070128258 Emulsion-containing medical articles
06/07/2007US20070128257 Animal wipes having catnip
06/07/2007US20070128256 Soluble cosmetic article with a thermal effect
06/07/2007US20070128255 Coated substrate with properties of keratinous tissue
06/07/2007US20070128254 Methods of attaching a dosage form to a medicated tampon assembly
06/07/2007US20070128245 Porous calcium phosphate bone material
06/07/2007US20070128234 Process for the incorporation of a flavor or fragrance ingredient or composition into a carbohydrate matrix
06/07/2007US20070128231 Phosphate-buffered solution with a pH of 5.9 to 6.8 containing tris(hydroxymethyl)aminomethane as a stabilizer; does not contain amino acids or human serum albumin; may also contain NaCl, ethylenediaminetetraacetic acid, and a nonionic detergent such as a polysorbate
06/07/2007US20070128175 Novel hydorgels and uses thereof
06/07/2007US20070128173 Use of polysulphated alginate in cellular matrices
06/07/2007US20070128167 Complexing agents for compositions containing inclusion complexes
06/07/2007US20070128156 Ophthalmic compositions containing a synergistic combination of two polymers
06/07/2007US20070128142 Emulsion for conveying a hydrophobic active material to a substrate in aqueous medium
06/07/2007US20070128130 Remineralizing dental adhesive film
06/07/2007US20070128126 Airway Alkalinization as Therapy for Airway Diseases
06/07/2007US20070128125 Pharmaceutical Compositions Based on Tiotropium Salts and Salts of Salmeterol
1 ... 1421 1422 1423 1424 1425 1426 1427 1428 1429 1430 1431 1432 1433 1434 1435 1436 1437 1438 1439 1440 1441 ... 2991